ABSTRACT
Background
Illegible, incomplete and inappropriate prescriptions can lead to medication errors and adverse drug reactions. Dermatological conditions, despite their global prevalence, are often underestimated. This study assesses completeness, legibility and rationality of dermatological prescriptions in India.
Materials and Methods
The cross-sectional, observational study analyzed 3290 prescriptions at dermatology outpatient department of a tertiary care hospital. Ethical clearance was obtained. Participants signed written informed consent. Prescriptions from first time visitors containing at least one drug were included. Data were collected and analyzed for completeness, legibility, prescribed medicines and rational drug using descriptive statistics.
Results
All prescriptions were handwritten, with 37.33% in capital letters. Prescription legibility scored illegible in 1.5% and barely legible in 4%. While all prescriptions included patient information and date, essential drug information was lacking: dose (47.03%), route of administration (73.57%), frequency (46%), strength (60.44%) and duration (65.58%). Diagnosis and prescriber’s signature were missing in 19.67% and 8% prescriptions respectively. A total of 9607 drugs were prescribed, 81.39% individually and 18.6% as fixed dose combinations. Antifungals were prescribed the maximum (20.71%). Antibiotics were included in 37% of prescriptions. Average number of drugs per prescription was three with 40.07% prescribed from National List of Essential Medicines. Trade names were used in 88.17% prescriptions.
Conclusion
Prescriptions should be complete, legible and written in capital or generated by a computer to prevent errors. Dermatology practitioners should prescribe by generic names using essential drug list, adhere to clinical guidelines and limit number of drugs per prescription to promote rational therapeutics. These findings can guide future policies and interventions.
INTRODUCTION
Skin disorders are widespread, affecting nearly one-third of the world’s population. They constitute to be the 4th most common cause of non-fatal disease burden worldwide, although their burden often remains underestimated. According to the Global Burden of Disease Study 2017, skin diseases result in 30 to 40 months of life lost due to disability for an adult. These conditions worsen the quality of life due to increased physical, social and psychological distress. They also impose a high financial burden owing to their chronic nature and the need for long-term therapy.
The rising prevalence of skin disorders significantly contributes to the global healthcare burden.1–3
Dermatology offers a variety of drugs and combination products for treating skin disorders, employing both topical and oral therapies. Literature indicates that dermatologists prescribe nearly 5% of all antibiotics worldwide, often requiring extended treatment periods.4–6 Patients getting medications relevant to their diagnosis in amount that fulfill their need for a sufficient amount of time at a reasonable price is referred to as the rational use of medicines.7
Evaluation of prescription pattern is the gold standard to promote the rational use of drugs. Prescription is a fundamental component of healthcare, providing specific instructions for patient treatment. Irrational prescribing or inappropriate usage of drugs might result in negative side effects, long-term infections, emergence of antimicrobial resistance and unnecessary medical exposures.8,9 Illegible and incomplete prescriptions contribute to medication errors and adverse drug reactions, increasing treatment costs.
The World Health Organization (WHO) along with the International Network for the Rational Use of Drug (INRUD) have developed core drug use indicators for evaluating the rational use of drugs in healthcare settings, including prescribing, patient care and health facility indicators.10 Literature shows varied prescribing practices in dermatological disorders, such as high percentage of antibiotics prescribed per prescription, brand prescribing, polypharmacy and limited availability of drugs in developing countries. However, there are limited studies on the assessment of prescription patterns in Northern India, especially concerning aspects of legibility and completeness.11–13 Therefore, this cross-sectional and observational study was undertaken to evaluate the quality of prescriptions by assessing completeness, legibility and rationality at a dermatology outpatient department of a tertiary care hospital in India, serving rural and semi-urban populations.
MATERIALS AND METHODS
Study design and setting
This was a cross-sectional and observational study conducted over a period of 12 months at the dermatology Outpatient Department (OPD) of a tertiary care teaching hospital in India catering to rural and semi urban populations.
Ethical considerations
Ethical clearance was obtained from the Institutional Ethics Committee (IEC), registered by CDSCO, MOHFW and DHR, ICMR according to ICMR/GCP guidelines. Written informed consent of the patients was taken before participating in the study. A patient information sheet was given to them and explained the purpose and details of the study in a simple manner. The confidentiality of the patient’s details was maintained. As the study was observational in nature, the patients were not subjected to any harm or risk.
Patient Selection
The prescriptions of patients who visited the outpatient department of dermatology at the tertiary care hospital for the first time and/or newly diagnosed patients were included. The prescriptions from patients who refused to participate or contained no prescribed drugs were excluded. Overall, 3290 prescriptions were analyzed.
Data collection and analysis
Patients were selected randomly. Data were collected from prescriptions and filled into the standard data collection form. Prescriptions were evaluated for completeness including date, patient information, diagnosis, treatment details and prescriber particulars. Prescriptions were assessed for legibility by three pharmacists as per 4-point legibility scoring Likert scale.14 The prescriptions were categorized as Grade one, when completely illegible; Grade two; when barely legible and required expertise of pharmacists; Grade three, when most of the things in prescriptions were moderately legible and Grade four, when prescriptions were completely legible. Further, the data were analyzed for medication patterns for various skin disorders and rationality using WHO’s drug prescribing indicators. Descriptive statistics were used to calculate frequency, averages and percentages.
RESULTS
Completeness of Prescriptions
3290 (100% of prescriptions) had complete typed information of the patients, including name, age, gender, address of the patient, registration number along with the date. Diagnosis was written in 2642 (80.33% of prescriptions). Past studies showed that the diagnosis was written in 64.2% and 75.35% of prescriptions respectively.15,16 Chief complaints were mentioned in 1870 (56.83% of prescriptions). Recording of salient features related to physical examination were mentioned in 1831(55.66% of prescriptions). Patient’s history was mentioned in 1338 (40.66% of prescriptions). Results of laboratory tests investigations were mentioned in 1629 (49.5% of prescriptions). Allergy status of the patient was mentioned in 921 (28% of prescriptions). Table 1 shows the essential information about drugs was missing in several prescriptions. A rubber stamp was used for marking prescriber’s information including the name, designation and registration number in prescriptions, however it was found in 2303 (70% of prescriptions). The signature of the prescriber was mentioned in 3026 (92% of prescriptions).
Essential information of drugs in prescriptions | Mentioned for drugs (Prescription Completeness) | Not mentioned for drugs (Prescription incompleteness) |
---|---|---|
Strength | 3801(39.56%) | 5806(60.44%) |
Frequency | 5188(54%) | 4419(46%) |
Quantity | 5089(52.97%) | 4518(47.03%) |
Duration | 3306(34.41%) | 6301(65.58%) |
Route of administration | 2539(26.42%) | 7068(73.57%) |
Legibility Score of Prescriptions
All prescriptions 3290 (100%) were handwritten. 1228 (37.33%) of prescriptions were written in capital letters. Legibility score of Grade 1 was found in 49 (1.5% of prescriptions) indicating completely illegible prescriptions. 132 (4% of prescriptions) had Grade score 2; indicating barely legible prescriptions. 1881 (57.16% of prescriptions) had a Grade score of 3 indicating that most of the things in the prescriptions were moderately legible. 1228 (37.33%) of prescriptions were found to have a grade score of 4, reflecting completely legible prescriptions (Figure 1). Similar results were shown in the study carried out in 2021 with 68.5% of prescriptions were easily legible, 20% of prescriptions had difficult legibility and 11.5% of prescriptions were found to be illegible.17
Prevalence of Skin Disorders
Figure 2 shows the various types of skin diseases affecting people in regions surrounding the tertiary care hospital in Haryana. Acne was the most common disease in 430 (13.07% of prescriptions). 940 (28.57% of prescriptions) indicated miscellaneous disorders out of which 165 (17.54%) were infectious diseases such as pruritus, balanoposthitis, furunculosis, chicken pox, panniculitis and herpes zoster. 775 (82.46%) of miscellaneous were non-infectious diseases including alopecia, hirsutism, intertrigo, edema, lichen planus, pseudofolliculitis, allergic rashes etc. Comparing the results with a previous study, it was found that Tinea (15.25%), acne (12.36%) and drug-induced cutaneous responses (10.11%) were the three most prevalent ‘disorders.18
Pattern of Drugs, Fixed Dose Combination, Dosages form Prescribed for Skin Disorders
3290 prescriptions contained a total of 9607 drugs including drugs prescribed individually 7819 (81.39% of drugs) and as combination products 1790 (18.63% of drugs). Results indicating the pattern of drug use are shown in Figure 3. Antifungals were prescribed the maximum; 1990 (20.71%) of drugs. Miscellaneous drugs including antivirals, insect repellants, pigmentation correctors and antimetabolites constituted 500 (5.20% of drugs).
Our results were similar to a previous study,18 yet in contrast from others4,10 where antihistamines were the most prescribed. In addition to these, skin care products such as oils, facewash, moisturizing creams and lotions, serum and hair oils, lip balms and sunscreen lotions were prescribed to form 1961 (16.96% of all drugs and cosmetics).
Our study showed that 4046 (42.12% of the drugs prescribed) were meant for topical use including creams, ointments, lotions, medicated soaps and powders, whereas 5561 (57.88% of the prescribed drugs) were oral formulations including tablets, capsules and syrups. The use of parenteral formulations was absent. Antibiotics, antifungal agents and antihistamines were prescribed for both topical as well as oral use. Antibacterial agents were prescribed as soaps or lotions. Steroids were mostly prescribed as topical, whereas NSAID’s were prescribed as oral formulations. Interestingly, our results were found to be opposite to the results obtained in a study conducted in 2015, where oral formulations were prescribed in lesser number than topical formulations.14 Another study showed that the most common dosage form was tablet (44.49%) followed by cream (24.05%).18,19
WHO Drug Prescribing Indicators
Average number of drugs per prescription aims to determine the extent of polypharmacy practice at health care setting.20 Figure 4 shows the number of drugs prescribed to patients. Average number of drugs per prescription as three was found to be comparable to the results of the past studies where it was found as 3.35, 3, 3.02 and 3.68 respectively.18,21–23 1270 (38.61% of prescriptions) contained drugs below or equal to two. Current result also indicates that 290 (8.82% of prescriptions) contained five or more than five drugs.
All the prescribed medications in 389 (11.83% of prescriptions) were written by their generic names, whereas 2901 (88.17%) prescriptions had medicines written by their trade names. Nearly similar results were obtained in earlier studies, where 3.6% and 6.95% of drugs were prescribed with generic names respectively.21,24 On the contrary, several studies showed more than 50% of drugs prescribed by generic names, as reported with 77.3%, 85.8% and 50.33% generic names prescribing respectively.22,25,26
From a total of 9607 drugs prescribed to 3290 patients, 1439 (14.98% of drugs) were antibiotics. 1020 (31% of prescriptions) contained a single antibiotic in them. In contrast, a previous study had 73.85% of prescriptions with antibiotics.27 Similarly, several studies showed a higher percentage of antibiotics per prescription as 65.33%, 58% and 51.5%.24,26,28
This indicator determines number of times where an injectable drug is prescribed. It is noteworthy to mention here, that vaccinations are not considered as injections. Results showed that no injections were prescribed.
3850 (40.07% of drugs) were prescribed from India’s National List of Essential Medicines 2022 or the hospital formulary. Past studies indicate as low as 12% and 9% of drugs prescribed from EDL.18,21 Few studies on the other hand showed 88.3% and 84% of drugs respectively prescribed from the EDL.22,29
DISCUSSION
Dermatological diseases affect people of all ages. The diagnosis written in the prescriptions reflected the prevalence of skin disorders among semi-urban people in Northern India. The results of the pattern of drug use were in corroboration with the diagnosis mentioned in the prescriptions. Antifungals were prescribed the maximum, followed by fixed dose combinations of steroids with antifungals, steroids, antibiotics, antihistamines, NSAID’s and antibacterials. Selection of systemic or topical therapy depends on factors related to disease, patient and physician. It is simpler to prescribe an oral formulation than prescribe, educate and motivate a patient to use topical therapy, however, such kinds of practices should never be followed.19 Literature reports that patients tend to continue their treatment beyond the prescribed duration due to peer pressure, quick feel-good effect and lack of knowledge about harmful effects, in case of topical corticosteroids.19
It is of prime importance to mention the complete and correct details of the patient for medico-legal purposes. It further ensures that the patient receives drug therapy in the right amount as per the diagnosis. The patient’s details with date are printed at the time of registration, due to which our results are found to be highly favorable. Our study showed that diagnosis was not written in few prescriptions. Writing diagnosis in all the prescriptions is essential and could avoid medication errors. The determination of diagnosis is an important component of rational prescribing. The essential information of prescribed medications including dose, quantity, frequency, administration route and duration were not filled for all, making the prescriptions incomplete. The strength quantity, frequency and duration of drug therapy are critical parameters, which, if not clearly documented, can lead to ambiguity and errors.12 Abbreviations for dosage forms such as T/tab for tablets, C/cap for capsules, Cr/C for creams, Oint for ointment, syp for syrup were observed frequently in our study. In general, physicians should avoid writing abbreviations in prescriptions. Illegible prescriptions can lead to mistakes. Poor communication in the form of illegible prescriptions can lead to confusion and errors; for example, drug names having similar spellings such as Clobetasol and Clobetasone may be dispensed or used interchangeably, if not written clearly. The study suggested the need of typed prescriptions for complete legibility.
One of the important indicators of rational drug use is determination of number of drugs per prescription.7,22 The average number of drugs prescribed per prescription as per WHO should be less than 2, with an optimal range of 1.6 to 1.8. Polypharmacy is defined as use of multiple drugs (>5) in a patient.30 When multiple drugs are used, the chances of adverse drug reactions, the risk of drug interactions and dispensing errors increases many folds. Higher number of drugs also led to decrease in medication adherence and elevate unnecessary expenses. As per the regulations, every physician should as far as possible prescribe using generic names, in capital letters, legibly and ensure the rationality, however, the confusion prevails due to availability of branded generics and lack of stringent regulations for bioequivalence testing in India, which could possibly be one of the reasons for low prescribing using generic names in our study.31
The frequency of antibiotic prescribing practice was found to be far less in contrast to previous studies that were suggestive of misuse of antibiotics and contributed to antimicrobial resistance.27 The result for number of injections per prescription was in accordance with the guidelines of WHO, that recommends not to use injection when other forms of the drugs are available and thus reflects good prescribing practices. Our study indicates that improvement in prescribing the drugs listed from WHO’s EDL/ (NLEM in India) or a standard formulary is highly recommended the most recent list; NLEM of 2022 has included certain drugs used for the treatment of skin disorders such as Itraconazole and Terbinafine and deleted Cetrimide. These must be accounted for while prescribing, to make patients gain access to affordable rational treatment.
CONCLUSION
Studying the prescription pattern is a helpful tool to ensure rationality in prescriptions and establishing the criteria of optimum drug use and limiting medication errors. Skin diseases although widespread, are often underestimated and neglected. Analysis of prescription pattern describe the scope and patterns of drug use, current medication trends, quality of medications, adherence to standard guidelines, use of medicines from the essential drug list and usage of generic medications. Rational prescription in dermatological diseases can help to maximize clinical effectiveness and minimize the harm to the patient. The present study encourages the healthcare practitioners in dermatology to adhere to clinical guidelines, prescribe the medicines by generic names and from the essential drug list, keep drugs prescribed per prescription as low as possible, thereby enhance rational therapeutics. The prescriptions should be complete in all aspects and written in capital or computer-generated to avoid medication errors. This study could serve as the basis for policymakers and intervention studies in the future.
Cite this article:
Kipa A, Mohinder SP, Sonal S. Quality Evaluation of Dermatology Prescriptions: Completeness, Legibility and Rationality in a Tertiary Care Indian Hospital. J Young Pharm. 2025;17(1):219-25.
ACKNOWLEDGEMENT
The authors are thankful to Department of Dermatology of Tertiary Care Hospital for permitting to perform the study.
ABBREVIATIONS
EDL | Essential Drug List |
---|---|
IEC | Institutional Ethics Committee |
INRUD | International Network for the Rational Use of Drug |
OPD | Outpatient Department |
NLEM | National List of Essential Medicines |
NSAID’s | Non-steroidal anti-inflammatory drugs |
WHO | World Health Organization |
References
- Seth D, Cheldize K, Brown D, Freeman EF. Global burden of skin disease: inequities and innovations. Curr Dermatol Rep. 2017;6(3):204-10. [PubMed] | [CrossRef] | [Google Scholar]
- Flohr C, Hay R. Putting the burden of skin diseases on the global map. Br J Dermatol. 2021;184(2):189-90. [PubMed] | [CrossRef] | [Google Scholar]
- Kavita A, Thakur JS, Narang T. The burden of skin diseases in India: global burden of disease study 2017. Indian J Dermatol Venereol Leprol. 2023;89(3):421-5. [PubMed] | [CrossRef] | [Google Scholar]
- Pathak AK, Kumar S, Kumar M, Mohan L, Dikshit H. Study of drug utilization pattern for skin diseases in dermatology OPD of an Indian tertiary care hospital – A prescription survey. J Clin Diagn Res. 2016;10(2):FC01-5. [PubMed] | [CrossRef] | [Google Scholar]
- Chon SY, Doan HQ, Mays RM, Singh SM, Gordon RA, Tyring SK, et al. Antibiotic overuse and resistance in dermatology. Dermatol Ther. 2012;25(1):55-69. [PubMed] | [CrossRef] | [Google Scholar]
- Divyashanthi C, Nandhini A, Kumar SA. Study on drug utilization pattern of antibiotics among dermatology in-patients of a tertiary care teaching hospital, Karaikal, Puducherry. Int J Basic Clin Pharmacol. 2014;3(6):1072-7. [CrossRef] | [Google Scholar]
- Bandyopadhyay D, Panda S. Rational use of drugs in dermatology: A paradigm lost?. Indian J Dermatol Venereol Leprol. 2018;84(1):1-5. [PubMed] | [CrossRef] | [Google Scholar]
- Ofori-Asenso R, Agyeman AA. Irrational use of medicines-A summary of key concepts. Pharmacy (Basel). 2016;4(4):35 [PubMed] | [CrossRef] | [Google Scholar]
- Chandra S, Prithvi PP, Srija K, Jauhari S, Grover A. Antimicrobial resistance: call for rational antibiotics practice in India. J Fam Med Prim Care. 2020;9(5):2192-9. [PubMed] | [CrossRef] | [Google Scholar]
- Patil B, Patil J, Hugar L, Moharir G. Analysis of prescribing practices in the dermatology outpatient department of a tertiary care teaching hospital. Cureus. 2023;15(4):e37910 [PubMed] | [CrossRef] | [Google Scholar]
- Naaz R, Shetty S, Chand S, Nandakumar UP, Vinay BC, Bharath Raj KC, et al. Prospective observational study on prescribing pattern of antifungal drugs among the 400 out-patients in department of dermatology in a tertiary care hospital. Biomed Pharmacol J. 2021;14(1):311-6. [PubMed] | [CrossRef] | [Google Scholar]
- Weldemariam D, Amaha N, Abdu N. Assessment of completeness and legibility of handwritten prescriptions in six community chain pharmacies of Asmara, Eritrea: a cross-sectional study. BMC Heal Serv Res. 2020;20(570):1-7. [PubMed] | [CrossRef] | [Google Scholar]
- Gupta S, Khan W, Krishna A. Pattern of skin diseases and common drugs prescribed in dermatology OPD of an Indian tertiary care hospital. Int J Basic Clin Pharmacol. 2017;6(1):203-7. [CrossRef] | [Google Scholar]
- Ahmed NJ. Prescribing practices of medications in the outpatient dermatology department of a public hospital. J Pharm Res Int. 2021;33(2):70-4. [CrossRef] | [Google Scholar]
- Muhammad K, Amin MU, Khan FU, Ismael NS, Sabi-Ur-rehman AA. Prescription analysis of outpatients in a tertiary care hospital in Khyber pakhtunkhwa, Pakistan. Trop J Nat. Prod Res. 2021;5(4):643-8. [CrossRef] | [Google Scholar]
- Kumar D, Sharma L, Jakhar P, Bansal A, Rathore RS, Kumar S, et al. A prospective observational study of prescription pattern in dermatology outpatient department of associated hospitals of Rajasthan University of Health Sciences-College of Medical Sciences, Jaipur. Int J Basic Clin Pharmacol. 2023;12(3):402-5. [CrossRef] | [Google Scholar]
- Bhowmick S, Jana S, Parolia S, Das A, Saren P. Prescription audit study from a tertiary care private hospital. QAI J Heal Qual Patient S Afr. 2019;1(1):13-8. [CrossRef] | [Google Scholar]
- Krishna J, Singh A, Goel S, Roy A, Singh AK, Yadav KP, et al. Clinical pharmacological study of Prescribing Pattern of Dermatological drugs from a tertiary care Teaching Hospital. Indian J Sci Res. 2015;6(2):41-5. [CrossRef] | [Google Scholar]
- Rathi SK, D’Souza P. Rational and ethical use of topical corticosteroids based on safety and efficacy. Indian J Dermatol. 2012;57(4):251-9. [PubMed] | [CrossRef] | [Google Scholar]
- Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230 [PubMed] | [CrossRef] | [Google Scholar]
- Sunny D, Roy K, Benny SS, Mathew DC, Gangadhar Naik J, Gauthaman K, et al. Prescription audit in an outpatient pharmacy of a tertiary care teaching hospital-A prospective study. J Young Pharm. 2019;11(4):417-20. [CrossRef] | [Google Scholar]
- Singh T, Banerjee B, Garg S, Sharma S. A prescription audit using the World Health Organization-recommended core drug use indicators in a rural hospital of Delhi. J Educ Heal Promot. 2019;8(1):37 [CrossRef] | [Google Scholar]
- Bansal P, Baishnab S, Singla A. Drug prescribing pattern of antifungal drugs for local fungal infections in a tertiary care hospital: MAMC, Agroha. Int J Basic Clin Pharmacol. 2021;10(6):689 [CrossRef] | [Google Scholar]
- Muhammad K, Amin MU, Khan FU, Ismael NS, Sabi-Ur-rehman AA. Prescription analysis of outpatients in a tertiary care hospital in Khyber pakhtunkhwa, Pakistan. Trop J Nat. Prod Res. 2021;5(4):643-8. [CrossRef] | [Google Scholar]
- Lakshmi GN, Priyanka C, Vineela M. Drug utilisation pattern in dermatology outpatient department at a tertiary care hospital. Int J Basic Clin Pharmacol. 2018;7(11):2101 [CrossRef] | [Google Scholar]
- Aryal A, Dahal A, Shrestha R. Study on drug use pattern in primary healthcare centers of Kathmandu valley. SAGE Open Med. 2020;8:2050312120926437 [PubMed] | [CrossRef] | [Google Scholar]
- Sharma M, Payal N, Devi LS, Gautam D, Khandait M, Hazarika K, et al. Study on prescription audit from a rural tertiary Care Hospital in North India. J Pure Appl Microbiol. 2021;15(4):1931-9. [CrossRef] | [Google Scholar]
- Sema FD, Asres ED, Wubeshet BD. Evaluation of rational use of medicine using WHO / INRUD core drug use indicators at Teda and Azezo health centers, Gondar town, Northwest Ethiopia. Integr Pharm Res Pract. 2021;10:51-63. [PubMed] | [CrossRef] | [Google Scholar]
- Tripathy JP, Bahuguna P, Prinja S. Drug prescription behavior: A cross-sectional study in public health facilities in two states of North India. Perspect Clin Res. 2018;9(2):76-82. [PubMed] | [CrossRef] | [Google Scholar]
- Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230 [PubMed] | [CrossRef] | [Google Scholar]
- Roy V, Rana P. Prescribing generics: all in a name. Indian J Med Res. 2018;147(5):442-4. [PubMed] | [CrossRef] | [Google Scholar]